LIN28A and cancer: IGF2BP is predominantly localized in the cytoplasmic fraction and is considered to stabilize pre-mRNA as a reader of N6-methyladenosine (m6A), inhibit RNA decay, and enhance the expression of oncogenes such as MYC and LIN28 in multiple types of cancers [75].